Literature DB >> 23142790

Genotoxicity of polyvinylpyrrolidone-coated silver nanoparticles in BEAS 2B cells.

Penny Nymark1, Julia Catalán, Satu Suhonen, Hilkka Järventaus, Renie Birkedal, Per Axel Clausen, Keld Alstrup Jensen, Minnamari Vippola, Kai Savolainen, Hannu Norppa.   

Abstract

Silver nanoparticles (AgNPs) are widely utilized in various consumer products and medical devices, especially due to their antimicrobial properties. However, several studies have associated these particles with toxic effects, such as inflammation and oxidative stress in vivo and cytotoxic and genotoxic effects in vitro. Here, we assessed the genotoxic effects of AgNPs coated with polyvinylpyrrolidone (PVP) (average diameter 42.5±14.5 nm) on human bronchial epithelial BEAS 2B cells in vitro. AgNPs were dispersed in bronchial epithelial growth medium (BEGM) with 0.6 mg/ml bovine serum albumin (BSA). The AgNP were partially well-dispersed in the medium and only limited amounts (ca. 0.02 μg Ag(+) ion/l) could be dissolved after 24h. The zeta-potential of the AgNPs was found to be highly negative in pure water but was at least partially neutralized in BEGM with 0.6 mg BSA/ml. Cytotoxicity was measured by cell number count utilizing Trypan Blue exclusion and by an ATP-based luminescence cell viability assay. Genotoxicity was assessed by the alkaline single cell gel electrophoresis (comet) assay, the cytokinesis-block micronucleus (MN) assay, and the chromosomal aberration (CA) assay. The cells were exposed to various doses (0.5-48 μg/cm(2) corresponding to 2.5-240 μg/ml) of AgNPs for 4 and 24 h in the comet assay, for 48 h in the MN assay, and for 24 and 48 h in the CA assay. DNA damage measured by the percent of DNA in comet tail was induced in a dose-dependent manner after both the 4-h and the 24-h exposures to AgNPs, with a statistically significant increase starting at 16 μg/cm(2) (corresponding to 60.8 μg/ml) and doubling of the percentage of DNA in tail at 48 μg/cm(2). However, no induction of MN or CAs was observed at any of the doses or time points. The lack of induction of chromosome damage by the PVP-coated AgNPs is possibly due to the coating which may protect the cells from direct interaction with the AgNPs, either by reducing ion leaching from the particles or by causing extensive agglomeration of the nanoparticles, with a possible reduction of the cellular uptake.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chromosomal damage; DNA damage; Human bronchial epithelial cells; Micronuclei; Silver nanoparticles

Mesh:

Substances:

Year:  2012        PMID: 23142790     DOI: 10.1016/j.tox.2012.09.014

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  24 in total

1.  Silver nanoparticles: correlating nanoparticle size and cellular uptake with genotoxicity.

Authors:  Kimberly S Butler; David J Peeler; Brendan J Casey; Benita J Dair; Rosalie K Elespuru
Journal:  Mutagenesis       Date:  2015-05-11       Impact factor: 3.000

2.  Culture conditions profoundly impact phenotype in BEAS-2B, a human pulmonary epithelial model.

Authors:  Fei Zhao; Walter T Klimecki
Journal:  J Appl Toxicol       Date:  2014-12-19       Impact factor: 3.446

3.  Hazard Assessment of Benchmark Metal-Based Nanomaterials Through a Set of In Vitro Genotoxicity Assays.

Authors:  Maria Dušinská; Maria João Silva; Nádia Vital; Mariana Pinhão; Naouale El Yamani; Elise Rundén-Pran; Henriqueta Louro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Acute intravenous exposure to silver nanoparticles during pregnancy induces particle size and vehicle dependent changes in vascular tissue contractility in Sprague Dawley rats.

Authors:  A K Vidanapathirana; L C Thompson; M Herco; J Odom; S J Sumner; T R Fennell; J M Brown; C J Wingard
Journal:  Reprod Toxicol       Date:  2017-11-21       Impact factor: 3.143

5.  Assessment of genotoxicity of silver nanoparticles on lymphocyte cells of albino rats using comet assay.

Authors:  Mai I Salama; Doaa A El Morsi; Osama Shabka; Nermin M Emam
Journal:  Toxicol Res (Camb)       Date:  2021-10-13       Impact factor: 2.680

6.  Cell type-dependent changes in CdSe/ZnS quantum dot uptake and toxic endpoints.

Authors:  Bella B Manshian; Stefaan J Soenen; Abdullah Al-Ali; Andy Brown; Nicole Hondow; John Wills; Gareth J S Jenkins; Shareen H Doak
Journal:  Toxicol Sci       Date:  2015-01-19       Impact factor: 4.849

Review 7.  Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity.

Authors:  Stephen J Evans; Martin J D Clift; Neenu Singh; Jefferson de Oliveira Mallia; Michael Burgum; John W Wills; Thomas S Wilkinson; Gareth J S Jenkins; Shareen H Doak
Journal:  Mutagenesis       Date:  2016-11-04       Impact factor: 3.000

8.  Lack of Detectable Direct Effects of Silver and Silver Nanoparticles on Mitochondria in Mouse Hepatocytes.

Authors:  Lu Wang; Danielle F Mello; Robert M Zucker; Nelson A Rivera; Nicholas M K Rogers; Nicholas K Geitner; William K Boyes; Mark R Wiesner; Heileen Hsu-Kim; Joel N Meyer
Journal:  Environ Sci Technol       Date:  2021-08-04       Impact factor: 9.028

9.  Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials.

Authors:  Amy J Clippinger; Arti Ahluwalia; David Allen; James C Bonner; Warren Casey; Vincent Castranova; Raymond M David; Sabina Halappanavar; Jon A Hotchkiss; Annie M Jarabek; Monika Maier; William Polk; Barbara Rothen-Rutishauser; Christie M Sayes; Phil Sayre; Monita Sharma; Vicki Stone
Journal:  Arch Toxicol       Date:  2016-04-27       Impact factor: 5.153

10.  Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis.

Authors:  Dávid Kovács; Nóra Igaz; Csilla Keskeny; Péter Bélteky; Tímea Tóth; Renáta Gáspár; Dániel Madarász; Zsolt Rázga; Zoltán Kónya; Imre M Boros; Mónika Kiricsi
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.